blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3542818

EP3542818 - INFECTIOUS DISEASE VACCINE USING NON-INFECTIOUS PARAMYXOVIRUS PARTICLE [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  15.12.2023
Database last updated on 24.08.2024
FormerRequest for examination was made
Status updated on  23.08.2019
FormerThe international publication has been made
Status updated on  25.05.2018
Most recent event   Tooltip15.12.2023Withdrawal of applicationpublished on 17.01.2024  [2024/03]
Applicant(s)For all designated states
Japan as Represented by The Director-General of National Institute of Infectious Diseases
1-23-1 Toyama
Shinjuku-ku
Tokyo 162-8640 / JP
For all designated states
ID Pharma Co., Ltd.
2-10-2 Fujimi
Chiyoda-ku
Tokyo 102-0071 / JP
[2019/39]
Inventor(s)01 / MATANO, Tetsuro
c/o National Institute of Infectious Diseases
1-23-1 Toyama
Shinjuku-ku
Tokyo 162-8640 / JP
02 / INOUE, Makoto
c/o ID Pharma Co. Ltd.
2-10-2 Fujimi
Chiyoda-ku
Tokyo 102-0071 / JP
03 / HARA, Hiroto
c/o ID Pharma Co. Ltd.
2-10-2 Fujimi
Chiyoda-ku
Tokyo 102-0071 / JP
04 / SHU, Tsugumine
c/o ID Pharma Co. Ltd.
2-10-2 Fujimi
Chiyoda-ku
Tokyo 102-0071 / JP
 [2019/39]
Representative(s)Schiweck Weinzierl Koch Patentanwälte Partnerschaft mbB
Ganghoferstraße 68 B
80339 München / DE
[2019/39]
Application number, filing date17871536.317.11.2017
[2019/39]
WO2017JP41492
Priority number, dateJP2016022447517.11.2016         Original published format: JP 2016224475
[2019/39]
Filing languageJA
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2018092887
Date:24.05.2018
Language:JA
[2018/21]
Type: A1 Application with search report 
No.:EP3542818
Date:25.09.2019
Language:EN
[2019/39]
Search report(s)International search report - published on:JP24.05.2018
(Supplementary) European search report - dispatched on:EP25.06.2020
ClassificationIPC:A61K39/21, A61K35/76, A61P31/18, A61K39/12, A61P31/14
[2020/31]
CPC:
A61K39/12 (EP); A61K39/21 (EP,US); A61K35/76 (EP);
A61P31/14 (EP); A61P31/18 (EP); C12N7/00 (US);
C12N2740/10022 (US); C12N2740/10034 (US); C12N2740/14034 (EP);
C12N2740/16034 (EP); C12N2760/18823 (US); C12N2760/18843 (EP,US) (-)
Former IPC [2019/39]A61K39/21, A61K35/76, A61P31/18
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2019/39]
TitleGerman:IMPFSTOFF GEGEN INFEKTIÖSE KRANKHEITEN UNTER VERWENDUNG VON NICHT-INFEKTIÖSEN PARAMYXOVIRUSPARTIKELN[2019/39]
English:INFECTIOUS DISEASE VACCINE USING NON-INFECTIOUS PARAMYXOVIRUS PARTICLE[2019/39]
French:VACCIN CONTRE DES MALADIES INFECTIEUSES UTILISANT DES PARTICULES DE PARAMYXOVIRUS NON INFECTIEUSES[2019/39]
Entry into regional phase06.06.2019Translation filed 
13.06.2019National basic fee paid 
13.06.2019Search fee paid 
13.06.2019Designation fee(s) paid 
13.06.2019Examination fee paid 
Examination procedure13.06.2019Examination requested  [2019/39]
22.01.2021Amendment by applicant (claims and/or description)
08.12.2023Application withdrawn by applicant  [2024/03]
Fees paidRenewal fee
26.11.2019Renewal fee patent year 03
24.12.2020Renewal fee patent year 04
24.11.2021Renewal fee patent year 05
24.11.2022Renewal fee patent year 06
Penalty fee
Additional fee for renewal fee
30.11.202004   M06   Fee paid on   24.12.2020
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[Y]US2002002143  (KANO MUNEHIDE [JP], et al) [Y] 1-15 * paragraph [0094] - paragraph [0096] ** Claims, examples *;
 [XY]WO2007064802  (MOUNT SINAI MEDICAL CT OF NEW [US], et al) [X] 1-5,7-15 * paragraph [00250] * * paragraph [00111] * * paragraph [00142] * * claims 24-26 * [Y] 6;
 [XY]EP2813574  (AMVAC AG [CH]) [X] 1-6,9-11,13-15 * paragraph [0091]; figure 1; claim 1 * * Examples * [Y] 7,8,12;
 [Y]  - TAKEDA A ET AL, "Evaluation of the immunogenicity of replication-competent V-knocked-out and replication-defective F-deleted Sendai virus vector-based vaccines in macaques", VACCINE, ELSEVIER, AMSTERDAM, NL, vol. 26, no. 52, doi:10.1016/J.VACCINE.2008.09.074, ISSN 0264-410X, (20081209), pages 6839 - 6843, (20081016), XP025711312 [Y] 1-15 * page 6839, column r, paragraph last * * abstract *

DOI:   http://dx.doi.org/10.1016/j.vaccine.2008.09.074
 [Y]  - T. MATANO ET AL, "Rapid Appearance of Secondary Immune Responses and Protection from Acute CD4 Depletion after a Highly Pathogenic Immunodeficiency Virus Challenge in Macaques Vaccinated with a DNA Prime/Sendai Virus Vector Boost Regimen", JOURNAL OF VIROLOGY, (20011201), vol. 75, no. 23, doi:10.1128/JVI.75.23.11891-11896.2001, ISSN 0022-538X, pages 11891 - 11896, XP055012404 [Y] 1-15 * abstract * * Results, Discussion *

DOI:   http://dx.doi.org/10.1128/JVI.75.23.11891-11896.2001
International searchWO0070070  [y] (DNAVEC RESEARCH INC [JP], et al) [y] 6,16;
 WO2014103310  [xy] (BIOCOMO INC [JP], et al) [x] 1-5,7,9,10,13,14,17 [y] 6,8,11,12,15,16;
 WO2016069518  [y] (INT AIDS VACCINE INITIATIVE [US], et al) [y] 6,8,11,12,15,16;
    [yY] - Ida, Akihiro et al., "Sendai Virus Vectors", Virus, (2003), vol. 53, no. 2, pages 171 - 175, XP009515020 [y] 6,16

DOI:   http://dx.doi.org/10.2222/jsv.53.171
by applicantWO9716539
 WO9716538
 WO0070055
 WO0070070
 WO0118223
 WO2005071092
 WO2005071085
 WO2016069518
    - SHARP PMHAHN BH, Cold Spring Harb Perspectives in Medicine, (20110000), vol. 1, no. 1, page a006841
    - CAMPO JE et al., AIDS and Clinical Research, (20120000), vol. S5, page 002
    - TSUKASAKI KTOBINAI K, Clin Cancer Res., (20140000), vol. 20, pages 5217 - 25
    - SATAKE M et al., J Med Virol, (20120000), vol. 84, pages 327 - 35
    - GONCALVES DU et al., Clinical Microbiol Rev, (20100000), vol. 23, pages 577 - 589
    - CARNEIRO-PROIETTI ABF et al., Journal of the Pediatric Infectious Diseases Society, (20140000), vol. 3, pages s24 - s29
    - HAYNES BF et al., Cell Host Microbel, (20160000), vol. 9, pages 292 - 303
    - STEPHENSON KE et al., Current Opinion in Immunology, (20160000), vol. 41, pages 39 - 46
    - GROSS CTHOMAS-KRESS AK, Viruses, (20160000), vol. 8, pages 74 - 95
    - RERKS-NGARM S et al., New Englan Journal of Medicine, (20090000), vol. 361, pages 2209 - 2220
    - ZHAO et al., Vacines, (20160000), vol. 4, pages 2 - 21
    - HAYNES BF et al., Cell Host Microbe, (20160000), vol. 19, pages 292 - 303
    - ZHAO et al., Vacines, (20160221), vol. 4
    - LAMB, R.A.D. KOLAKOFSKY, Paramyxoviridae: The viruses and their replication, (19960000), pages 1177 - 1204
    - Medical Journal of Osaka University, (19550300), vol. 6, no. 1, pages 1 - 15
    - LI, H.-O. et al., J. Virol., (20000000), vol. 74, no. 14, pages 6564 - 6569
    - ALTSCHUL, S. F. et al., J. Mol. Biol., (19900000), vol. 215, pages 403 - 410
    - ALTSCHUL S.F. et al., Nature Genet., (19930000), vol. 3, pages 266 - 272
    - MADDEN, T. L. et al., Meth. Enzymol., (19960000), vol. 266, pages 131 - 141
    - ALTSCHUL S.F. et al., Nucleic Acids Res., (19970000), vol. 25, pages 3389 - 3402
    - ZHANG J.MADDEN T. L., Genome Res., (19970000), vol. 7, pages 649 - 656
    - TATIANA A et al., FEMS Microbiol Lett., (19990000), vol. 174, pages 247 - 250
    - WU et al., J. Virol., (20060000), vol. 80, no. 2, pages 835 - 844
    - SHINGAI, M. et al., Proc Natl Acad Sci U.S.A., (20120000), vol. 109, no. 48, pages 19769 - 19774
    - HASAN, MK et al., J Gen Virol, (19970000), vol. 78, pages 2813 - 2820
    - KATO A et al., EMBO J, (19970000), vol. 16, pages 578 - 587
    - YU D et al., Genes Cells, (19970000), vol. 2, pages 457 - 466
    - KATO A et al., Genes Cells, (19960000), vol. 1, pages 569 - 579
    - TOKUSUMI T et al., Virus Res, (20020000), vol. 86, pages 33 - 38
    - LI HO et al., J Virol, (20000000), vol. 74, pages 6564 - 6569
    - HASAN, M. K. et al., J. General Virology, (19970000), vol. 78, pages 2813 - 2820
    - SEIKI, M. et al., Proc. Natl. Acad. Sci. U.S.A., (19830000), vol. 80, no. 12, pages 3618 - 3622
    - LI, H.-O. et al., J. Virology, (20000000), vol. 74, pages 6564 - 6569
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.